Earnings Feed
Start Free
Home/Insiders/Norton David Y
ND
SEC Insider//CIK 0001529193

Norton David Y

CIK 00015291935 companiesEAST BRUNSWICK, NJ
SEC Profile

Transactions

50

Companies

5

Filings

16

CIK

0001529193

Recent Transactions

50 trades
  • Award
    COMPASS Pathways plc$CMPS

    Share Option (Right to Buy)

    2025-06-12+26,000→ 26,000 total
  • Award
    COMPASS Pathways plc$CMPS

    Share Option (Right to Buy)

    2024-05-09+39,000→ 39,000 total
  • Award
    COMPASS Pathways plc$CMPS

    Share Option (Right to Buy)

    2023-06-02+26,000→ 26,000 total
  • Award
    COMPASS Pathways plc$CMPS

    Share Option (Right to Buy)

    2022-06-16+17,000→ 17,000 total
  • Sale
    COMPASS Pathways plc$CMPS

    Ordinary Shares

    2022-03-29$12.48/sh−3,384→ 20,356 total
  • Sale
    Keenova Therapeutics plc

    Ordinary Shares

    2021-08-05$0.26/sh−5,080→ 0 total
  • Sale
    Keenova Therapeutics plc

    Ordinary Shares

    2020-12-17$0.40/sh−5,080→ 0 total
  • Sale
    Keenova Therapeutics plc

    Ordinary Shares

    2020-12-16$0.43/sh−21,807→ 5,080 total
  • Tax Payment
    Keenova Therapeutics plc

    Ordinary Shares

    2020-05-13$2.96/sh−8,729→ 26,167 total
  • Award
    VIVUS INC

    Non-Qualified Stock Option (Right to Buy)

    2020-02-20+15,000→ 15,000 total
  • Award
    Keenova Therapeutics plc

    Ordinary Shares

    2019-05-15+19,396→ 34,896 total
  • Tax Payment
    Keenova Therapeutics plc

    Ordinary Shares

    2019-05-15$15.21/sh−8,527→ 15,500 total
  • Award
    VIVUS INC

    Non-Qualified Stock Option (Right to Buy)

    2018-10-26+15,000→ 15,000 total
  • Award
    Keenova Therapeutics plc

    Ordinary Shares

    2018-05-16+18,947→ 24,027 total
  • Tax Payment
    Keenova Therapeutics plc

    Ordinary Shares

    2018-03-01$15.68/sh−2,521→ 5,080 total
  • Purchase
    Keenova Therapeutics plc

    Ordinary Shares

    2017-11-10$22.02/sh+2,000→ 7,601 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2017-10-27+12,500→ 70,245 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2017-10-27−12,500→ 0 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2017-10-27$0.70/sh−3,125→ 67,120 total
  • Award
    VIVUS INC

    Non-Qualified Stock Option (right to buy)

    2017-10-27+150,000→ 150,000 total
  • Award
    Keenova Therapeutics plc

    Ordinary Shares

    2017-09-20+5,601→ 5,601 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2017-08-08−12,500→ 12,500 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2017-08-08+12,500→ 60,870 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2017-08-08$1.01/sh−3,125→ 57,745 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2017-06-15$1.17/sh−3,125→ 48,370 total
  • Award
    Syneos Health, Inc.

    Class A Common Stock

    2017-05-23+2,693→ 6,988 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2017-05-08+12,500→ 51,495 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2017-05-08−12,500→ 25,000 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2017-02-08+12,500→ 42,120 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2017-02-08$1.08/sh−3,125→ 38,995 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2017-02-08−12,500→ 37,500 total
  • Award
    VIVUS INC

    Restricted Stock Units

    2017-01-13+50,000→ 50,000 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2016-10-31+3,125→ 30,401 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2016-10-31$1.05/sh−781→ 29,620 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2016-10-31−3,125→ 0 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2016-09-30$1.14/sh−781→ 27,276 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2016-09-30−3,125→ 3,125 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2016-09-30+3,125→ 28,057 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2016-08-31$1.06/sh−788→ 24,932 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2016-08-31+3,125→ 25,720 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2016-08-31−3,125→ 6,250 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2016-07-31$1.07/sh−781→ 22,595 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2016-07-31−3,125→ 9,375 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2016-07-31+3,125→ 23,376 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2016-06-30$1.12/sh−781→ 20,251 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2016-06-30−3,125→ 12,500 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2016-06-30+3,125→ 21,032 total
  • Disposition to Issuer
    VIVUS INC

    Common Stock

    2016-05-30$1.23/sh−5,468→ 17,907 total
  • Exercise/Conversion
    VIVUS INC

    Common Stock

    2016-05-30+21,875→ 23,375 total
  • Exercise/Conversion
    VIVUS INC

    Restricted Stock Units

    2016-05-30−21,875→ 15,625 total

Companies

5

Recent Filings

16

Address

ONE TOWER CENTER BLVD. FLOOR 14

EAST BRUNSWICK, NJ, 08816

View on SEC.gov